Authors:
Landau, A
Batisse, D
Piketty, C
Van Huyen, LPD
Bloch, F
Belec, L
Bruneval, P
Weiss, L
Jian, R
Kazatchkine, MD
Citation: A. Landau et al., Long-term efficacy of combination therapy with interferon-alpha 2b and ribavirin for severe chronic hepatitis C in HIV-infected patients, AIDS, 15(16), 2001, pp. 2149-2155
Authors:
Landau, A
Batisse, D
Van Huyen, JPD
Piketty, C
Bloch, F
Pialoux, G
Belec, L
Petite, JP
Weiss, L
Kazatchkine, M
Citation: A. Landau et al., Efficacy and safety of combination therapy with interferon-alpha 2b and ribavirin for chronic hepatitis C in HIV-infected patients, AIDS, 14(7), 2000, pp. 839-844
Authors:
Landau, A
Batisse, D
Piketty, C
Jian, R
Kazatchkine, MD
Citation: A. Landau et al., Lack of interference between ribavirin and nucleosidic analogues in HIV/HCV co-infected individuals undergoing concomitant antiretroviral and anti-HCV combination therapy, AIDS, 14(12), 2000, pp. 1857-1858
Authors:
Meynard, JL
Barbut, F
Guiguet, M
Batisse, D
Lalande, V
Lesage, D
Guiard-Schmid, JB
Petit, JC
Frottier, J
Meyohas, MC
Citation: Jl. Meynard et al., Pseudomonas aeruginosa infection in human immunodeficiency virus infected patients, J INFECTION, 38(3), 1999, pp. 176-181